February 13, 2008 — The Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) initiative, funded by the National Institute of Mental Health (NIMH), has selected and tested ...
Psychosocial interventions offered limited benefits for reducing symptoms and substance use in patients with schizophrenia and comorbid substance use disorder.
A new study by researchers at King's College London has split schizophrenia risk into two genetically distinct pathways. One is characterized by a shared genetic risk with bipolar disorder and ...
Teva’s presentation of findings from six schizophrenia studies at Psych Congress 2024 highlights its commitment to finding new innovations in neuroscience Data show TEV-'749 drug delivery technology ...
A simple cheek swab could one day provide a quick and noninvasive diagnostic test for schizophrenia. A new study published in Science Advances has identified higher levels of two biological markers in ...
About 1% of Americans, or nearly 3.5 million people, are affected by schizophrenia — yet the mental disorder remains highly stigmatized and misunderstood, experts say. The reason, according to Brooke ...
Uncovering how rare genetic changes disrupt brain signaling and structure, this landmark study sheds new light on the roots of schizophrenia and opens doors for future therapies. Study: Whole-exome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results